Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company's product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology. The company was founded in 1998 and is headquartered in Beijing, China.
Frequently asked questions
What sector does Gaush Meditech Ltd (2407) operate in?
Gaush Meditech Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Gaush Meditech Ltd (2407) current stock price?
As of the latest data, Gaush Meditech Ltd stock price is HK$4.59, with a previous close of HK$4.43. Gaush Meditech Ltd gained HK$0.17 in the last trading session, representing a 3.73% increase.
What is Gaush Meditech Ltd (2407) current market capitalization?
Gaush Meditech Ltd market cap is approximately 678.81 million.
What is Gaush Meditech Ltd (2407) EBITDA?
Gaush Meditech Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 71.87 million.
Does Gaush Meditech Ltd (2407) pay dividends?
No. Gaush Meditech Ltd does not pay a dividend.
What is Gaush Meditech Ltd (2407) beta (volatility) score?
Gaush Meditech Ltd has a beta of 0.006, indicating lower volatility than the overall market.
